JPRN-UMIN000015830已完成2 期
Circulating tumor cells for EGFR-TKI resistance in NSCLC patients; prospective, multicenter study - CTC for EGFR-TKI resistance in NSCLC
Teikyo university school of medicine0 个研究点目标入组 30 人开始时间: 2014年12月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. HIV, HBV, HCV 2. History of Gefitinib, Erlotinib and crizotinib 3. Symptomatic brain metastasis 4. Presence of pulmonary fibrosis or interstitial pneumonia in chest CT 5. Active double cancer 6. Primary physician considered not to be suitable for the study.
研究者
相似试验
招募中
不适用
A study of the resistance mechanism of EGFR-TKI in EGFR gene mutation positive non-small cell lung cancerJPRN-UMIN000031013Kyoto prefectural University of Medicine35
已完成
2 期
Chemotherapy with EGFR-tyrosine kinase inhibitor (EGFR-TKI) or chemotherapy alone in elderly patients with advanced NSCLC with acquired resistance to EGFR-TKI (NEJ017)on-small cell lung cancerJPRN-UMIN000008364orth East Japan Study Group100
已完成
不适用
Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase in sensitizing EGFR mutation positive Non-Squamous Cell carcinoma patientsKCT0003243Koera University Guro Hospital69
Unknown
不适用
Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)Non Small Cell Lung CancerEGFR-TKI Resistant MutationEGFR-TKI Sensitizing MutationNCT02661009GenoSaber1,000
已完成
2 期
Multicenter phase II trial of continuous EGFR-TKIs for elderly patients with EGFR sensitive mutation who failed the first EGFR-TKIs treatment for advanced non-small cell lung cancer.JPRN-UMIN000008027ung Oncology Group in Kyushu, Japan (LOGIK)70